Library

feed icon rss

Your email was sent successfully. Check your inbox.

An error occurred while sending the email. Please try again.

Proceed reservation?

Export
Filter
  • 2005-2009  (1)
Material
Years
Year
  • 1
    Electronic Resource
    Electronic Resource
    Oxford, UK; Malden, USA : Blackwell Publishing Ltd/Inc.
    Journal of cutaneous pathology 32 (2005), S. 0 
    ISSN: 1600-0560
    Source: Blackwell Publishing Journal Backfiles 1879-2005
    Topics: Medicine
    Notes: Telomerase plays a role in the immortalization of cells and carcinogenesis. Previous studies have yielded conflicting results on whether human telomerase RNA (hTER) expression differs in nevi, atypical nevi and melanomas using PCR-based telomeric repeat amplification protocol (TRAP) or in situ hybridization assays. The aim of this study was to evaluate human telomerase reverse transcriptase (hTERT) staining in melanocytic lesions on paraffin-embedded tissues. Paraffin-embedded sections from 6 acquired nevi, 4 dysplastic nevi, 5 Spitz nevi, 6 primary invasive melanomas, and 3 metastatic melanomas, were studied for staining intensity (0–3+) and % of labeled cells with anti-hTERT. HTERT staining was observed in most cells (〉75%) in all lesions, and was of greater intensity in the nucleus, especially the nucleolus, compared to the cytoplasm. Spitz nevi tended to have weaker hTERT staining (mean = 1.2) compared to acquired nevi (mean = 2.0), dysplastic nevi (mean = 2.5), primary melanoma (mean = 2.17), or metastatic melanoma (mean = 3). Although telomerase activity was weaker in Spitz nevi, there was overlap with other nevi and primary invasive melanomas in our small series. Thus, hTERT expression does not appear to be a reliable adjunct to the histological diagnosis of primary melanocytic lesions.
    Type of Medium: Electronic Resource
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
Close ⊗
This website uses cookies and the analysis tool Matomo. More information can be found here...